3.000
+0,00%
2026-10-19
Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -64.1% | +50.3% | 1 / 3 | +106.1% | +4.57 pp | -3.90 pp | +11.9% | 1.98 | 4.44 | 1.946 | +106,1% | 18,9 | −58,9% | 4.44 | 2.26 | +96,5% |
| Pts | 0 | 12 | 4 | 12 | 12 | 0 | 0 | -4 | 4 | |||||||
Valuation annotation:Price: 3.000 (close price on 2026-10-19)EPS (TTM): 675,4
Financial charts
1.Revenue & growth
VND bn1.946Q2/26
1.Revenue & growth
VND bn1.946Q2/26
2.Profit & growth
VND bn18,3Q2/26
3.Profit mix (Penman)
VND bn288Q2/26
4.Margins & cost structure
%7.4%Q2/26
5.Returns & cash cycle
% · days3.6%Q2/26
6.Earnings quality & cash
VND bn526Q2/26
7.Asset structure
VND bn16.886Q2/26
8.Funding & debt health
VND bn · times16.886Q2/26
9.Revenue backlog
VND bn3.295Q2/26
10.Valuation
times · %4,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %53Q2/26
Adjusted EPS growth, latest quarter
-64.1%
Average adjusted EPS growth, 3 quarters
50.3%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26